Get the Stockscreener App
124.41
0.96%
1.18
After Hours:
122.01
-2.40
-1.93%
Irhythm Holdings Inc stock is traded at $124.41, with a volume of 270.95K.
It is up +0.96% in the last 24 hours and up +10.10% over the past month.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$123.23
Open:
$122.27
24h Volume:
270.95K
Relative Volume:
0.40
Market Cap:
$4.02B
Revenue:
$747.14M
Net Income/Loss:
$-44.55M
P/E Ratio:
-88.18
EPS:
-1.4108
Net Cash Flow:
$34.52M
1W Performance:
+3.25%
1M Performance:
+10.10%
6M Performance:
-29.18%
1Y Performance:
+23.48%
1-Day Range:
$121.64
$126.08
1-Week Range:
$114.26
$126.08
52-Week Range:
$97.16
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Name
Irhythm Holdings Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
124.41 | 3.98B | 747.14M | -44.55M | 34.52M | -1.4108 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Holdings Inc Stock (IRTC) Latest News
Julianne Rodda Net Worth (2026) - GuruFocus
iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results - ADVFN
iRhythm Holdings, Inc. (IRTC) reports $5.6M net income, 70.9% gross margin in Q4 2025 - MSN
Here's why you should retain IRTC stock in your portfolio for now - MSN
A Look At iRhythm Holdings (IRTC) Valuation After New ACC 2026 Clinical And AI Announcements - Sahm
Q4 2025 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Finviz
Goldman Sachs Lowers Price Target for IRTC to $147, Maintains Ne - GuruFocus
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm - marketscreener.com
The Bull Case For iRhythm Holdings (IRTC) Could Change Following New Auditor And AI Zio UpgradeLearn Why - Sahm
IRTC: Evercore ISI Group Lowers Price Target but Maintains Ratin - GuruFocus
iRhythm (IRTC) EVP Julianne Rodda discloses 20,313 shares and RSUs - Stock Titan
iRhythm Holdings (NASDAQ: IRTC) seeks approval for 2026 equity plan, elects nine directors - Stock Titan
IRTC Should I Buy - Intellectia AI
How The iRhythm Holdings (IRTC) Narrative Is Shifting With New Guidance And DOJ Overhang - Yahoo Finance
iRhythm Holdings appoints KPMG as new auditor, dismisses PwC By Investing.com - Investing.com Canada
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now - TradingView
iRhythm Holdings, Inc. Files Form 8-K: Company Information, Stock Details, and SEC Filing Data for March 2026 - Minichart
iRhythm Holdings appoints KPMG as new auditor, dismisses PwC - Investing.com
iRhythm (IRTC) switches from PwC to KPMG as independent auditor - Stock Titan
Data Presented at ACC.26 Demonstrate Benefits of iRhythm's Zio Ambulatory ECG Portfolio - National Today
iRhythm Presents Data Demonstrating Zio Ambulatory ECG Benefits Across Patient Populations - National Today
Data presented at ACC.26 further demonstrate the benefits of iRhythm's Zio ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform - Bitget
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform - The Manila Times
Studies found frequent arrhythmias in diabetes, kidney and obesity patients - Stock Titan
Free cash flow per share of iRhythm Holdings, Inc. – LSE:0A7L - TradingView
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) and iRhythm Technologies (NASDAQ:IRTC) - Defense World
Jason Patten Joins iRhythm Holdings’ Board of Directors - Medical Product Outsourcing
Vanguard lists zero holdings in iRhythm (NASDAQ: IRTC) - Stock Titan
Assenagon Asset Management S.A. Grows Stock Position in iRhythm Technologies $IRTC - MarketBeat
Here’s Artisan Mid Cap Fund’s Updates on iRhythm (IRTC) - msn.com
Q4 Patient Monitoring Earnings Review: First Prize Goes to iRhythm (NASDAQ:IRTC) - Yahoo Finance
[SCHEDULE 13G] iRhythm Holdings, Inc. Passive Investment Disclosure (>5%) - Stock Titan
IRTC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund - The Globe and Mail
This leading manufacturer of specialized heart monitors has recently attracted the attention of a prominent healthcare investment fund. - Bitget
iRhythm (IRTC) director granted 2,218 RSUs vesting from 2027 - Stock Titan
Director Jason H. Patten reports initial holdings in iRhythm Holdings (IRTC) - Stock Titan
How Investors Are Reacting To iRhythm Holdings (IRTC) Adding UnitedHealth Strategy Executive To Its Board - Sahm
Irhythm Holdings Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):